TGFB1 and cancer: TGFβ antibody therapy has proven to be very effective; since TGFβ can induce an inflammatory TME thereby lowering the efficacy of cancer and radiotherapy (RT) treatments, inhibiting the TGFβ pathway is likely to directly enhance the efficacy of RT (Chen et al., 2021a).